Di Carlo, Emma <br/><br/>
Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  May 2013 
 - 1034-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/mt.2013.38  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adoptive Transfer<br/>Animals<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Chemokine CXCL10--metabolism<br/>Combined Modality Therapy<br/>Cytotoxicity, Immunologic--drug effects<br/>Diphosphonates--administration & dosage<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Immunophenotyping<br/>Interferon-gamma--metabolism<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Mice<br/>Neovascularization, Pathologic<br/>Neuroblastoma--immunology<br/>Receptors, Antigen, T-Cell, gamma-delta--metabolism<br/>T-Lymphocyte Subsets--cytology<br/>Treatment Outcome<br/>Tumor Microenvironment--drug effects<br/>Xenograft Model Antitumor Assays<br/>Zoledronic Acid